Antisense-based therapy for the treatment of spinal muscular atrophy.

ABSTRACT: One of the greatest thrills a biomedical researcher may experience is seeing the product of many years of dedicated effort finally make its way to the patient. As a team, we have worked for the past eight years to discover a drug that could treat a devastating childhood neuromuscular disease, spinal muscular atrophy (SMA). Here, we describe the journey that has led to a promising drug based on the biology underlying the disease.

SUBMITTER: Rigo F 

PROVIDER: S-EPMC3461520 | biostudies-literature | 2012 Oct

REPOSITORIES: biostudies-literature